Showing results (41-50 of 101) with videos related to

Sort By:
Pageof 11
Journal of Public Health Research|August 5, 2021
Review of medicine utilization for Parkinson's disease management: the Bulgarian perspectiveZornitsa Mitkova, Maria Kamusheva, Dobrinka Kalpachka, et al.
British Journal of Clinical Pharmacology|September 9, 2025
Cost-benefit analysis of screening programme for diabetic retinopathy in BulgariaIva Nenkova, Yoana Lilova, Alexander Oscar, et al.
Healthcare (Basel, Switzerland)|February 13, 2025
Antidiabetic Medicines Utilisation During Pre-Pandemic, Pandemic and Post-Pandemic Period of COVID-19-Data for Bulgarian PopulationZornitsa Mitkova, Desislava Stanimirova, Miglena Manova, et al.
Biotechnology, Biotechnological Equipment|May 29, 2015
Economic consequences of the vaccination against hepatitis A in the Bulgarian healthcare settingMaria Dimitrova, Guenka Petrova, Konstantin Tachkov, et al.
Healthcare (Basel, Switzerland)|September 9, 2023
How Managed Entry Agreements Influence the Patients' Affordability to Biological Medicines-Bulgarian ExampleZornitsa Mitkova, Ivan Manev, Konstantin Tachkov, et al.
Biotechnology, Biotechnological Equipment|May 29, 2015
Comparison of health-related quality-of-life measurement instruments in diabetic patientsStanislava Yordanova, Valentina Petkova, Guenka Petrova, et al.
Frontiers in Public Health|September 9, 2021
Do Advanced Therapies Have a Future in the Low- and Middle-Income Countries - The Case of Bulgaria, Romania, and PolandMaria Kamusheva, Adina Turcu-Stiolica, Jakub Gierczyński, et al.
Healthcare (Basel, Switzerland)|February 25, 2022
Analysis of Healthcare Expenditures in BulgariaZornitsa Mitkova, Miglena Doneva, Nikolay Gerasimov, et al.
Biochemia Medica|March 6, 2013
Economic evaluation of different screening alternatives for patients with clinically suspected acute deep vein thrombosisNatasa Bogavac-Stanojević, Violeta Dopsaj, Zorana Jelić-Ivanović, et al.
Biomedicines|June 26, 2025
Ultrasound Evaluation of Therapeutic Response to Tofacitinib and Upadacitinib in Patients with Rheumatoid Arthritis-Real-Life Clinical DataVladimira Boyadzhieva, Konstantin Tachkov, Soner Emin, et al.
Pageof 11